{"id":70940,"date":"2020-09-03T10:31:47","date_gmt":"2020-09-03T10:31:47","guid":{"rendered":"https:\/\/scienze.fanpage.it\/?p=201433"},"modified":"2020-09-03T10:31:47","modified_gmt":"2020-09-03T10:31:47","slug":"il-vaccino-anti-covid-di-novavax-produce-una-forte-risposta-immunitaria-e-tra-i-piu-promettenti","status":"publish","type":"post","link":"https:\/\/nugnes.com\/?p=70940","title":{"rendered":"Il vaccino anti COVID di Novavax produce una forte risposta immunitaria: \u00e8 tra i pi\u00f9 promettenti"},"content":{"rendered":"<img src=\"https:\/\/static.fanpage.it\/wp-content\/uploads\/sites\/5\/2020\/04\/vaccinoinsviluppo-638x425.jpg\" \/><br \/>Grazie a uno studio clinico di Fase 1-2 randomizzato e controllato con placebo, \u00e8 stato determinato che il vaccino candidato \"NVX-CoV2373\" contro il coronavirus SARS-CoV-2 sviluppato da Novavax produce livelli elevati di anticorpi neutralizzanti e cellule T. Si basa su una tecnologia risultata gi\u00e0 efficace per altri vaccini, ma sar\u00e0 necessario attendere indagini pi\u00f9 approfondite per averne conferma.<br \/><a href=\"https:\/\/scienze.fanpage.it\/il-vaccino-anti-covid-di-novavax-produce-una-forte-risposta-immunitaria-e-tra-i-piu-promettenti\/\">Continua a leggere<\/a>","protected":false},"excerpt":{"rendered":"<p>Grazie a uno studio clinico di Fase 1-2 randomizzato e controllato con placebo, \u00e8 stato determinato che il vaccino candidato &#8220;NVX-CoV2373&#8221; contro il coronavirus SARS-CoV-2 sviluppato da Novavax produce livelli elevati di anticorpi neutralizzanti e cell&#8230;<\/p>\n","protected":false},"author":101,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[27],"tags":[],"class_list":["post-70940","post","type-post","status-publish","format-standard","hentry","category-salute"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/nugnes.com\/index.php?rest_route=\/wp\/v2\/posts\/70940","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nugnes.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nugnes.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nugnes.com\/index.php?rest_route=\/wp\/v2\/users\/101"}],"replies":[{"embeddable":true,"href":"https:\/\/nugnes.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=70940"}],"version-history":[{"count":1,"href":"https:\/\/nugnes.com\/index.php?rest_route=\/wp\/v2\/posts\/70940\/revisions"}],"predecessor-version":[{"id":70941,"href":"https:\/\/nugnes.com\/index.php?rest_route=\/wp\/v2\/posts\/70940\/revisions\/70941"}],"wp:attachment":[{"href":"https:\/\/nugnes.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=70940"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nugnes.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=70940"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nugnes.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=70940"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}